|
1
|
Yin J, Wang C, Mody A, et al: The effect
of Z-ligustilide on the mobility of human glioblastoma T98G gells.
PLoS One. 8:e665982013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang L, Du JR, Wang J, et al: Errata:
Z-ligustilide extracted from Radix Angelica Sinensis decreased
platelet aggregation induced by ADP ex vivo and arterio-venous
shunt thrombosis in vivo in rats. Yakugaku Zasshi. 134:4552014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peng B, Zhao P, Lu YP, et al:
Z-ligustilide activates the Nrf2/HO-1 pathway and protects against
cerebral ischemia-reperfusion injury in vivo and in vitro. Brain
Res. 1520:168–177. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feng Z, Lu Y, Wu X, et al: Ligustilide
alleviates brain damage and improves cognitive function in rats of
chronic cerebral hypoperfusion. J Ethnopharmacol. 144:313–321.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang YH, Wei YQ, Rong R and Yuan JR:
Determination of ligustilide in SFE extrate of SWT with HPLC.
Shanghai J Tradit Chin Med. 38:47–49. 2004.
|
|
6
|
Hou YZ, Zhao GR, Yuan YJ, Zhu GG and
Hiltunen R: Inhibition of rat vascular smooth muscle cell
proliferation by extract of Ligusticum chuanxiong and Angelica
sinensis. J Ethnopharmacol. 100:140–144. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu Q and Lou SH: Ligustilide regulates
vascular smooth muscle cells proliferation by MAPK signaling
pathway. Journal China Phamaceutical University. 26:632–634.
2010.
|
|
8
|
Lu Q, Qiu TQ and Yang H: Ligustilide
inhibits vascular smooth muscle cells proliferation. Eur J
Pharmacol. 542:136–140. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang L, Yang R, Wang M, et al:
Angiotensin II type-1 receptor-JAK/STAT pathway mediates the
induction of visfatin in angiotensin II-induced cardiomyocyte
hypertrophy. Am J Med Sci. 343:220–226. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou D, Liang Q, He X and Zhan C: Changes
of c-fos and c-jun mRNA expression in angiotensin II-induced
cardiomyocyte hypertrophy and effects of sodium tanshinone IIA
sulfonate. J Huazhong Univ Sci Technolog Med Sci. 28:531–534. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang T, Zhang W and Zhang L: L-Arginine-NO
pathway inhibits the hypertrophic response of cultured
cardiomyocytes induced by angiotensin II. Zhongguo Yao Li Xue Tong
Bao. 24:1361–1365. 2008.(In Chinese).
|
|
12
|
Liu J, Shen Q and Wu Y: Simvastatin
prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT
pathway. Life Sci. 82:991–996. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim M, Hunter RW, Garcia-Menendez L, et
al: Mutation in the γ2-subunit of AMP-activated protein kinase
stimulates cardiomyocyte proliferation and hypertrophy independent
of glycogen storage. Circ Res. 114:966–975. 2014.
|
|
14
|
Tu S, Liu ZQ, Fu JJ, Zhu WF, Luo DY and
Wan FS: Inhibitory effect of p53 upregulated modulator of apoptosis
targeting siRNA on hypoxia/reoxygenation-induced cardiomyocyte
apoptosis in rats. Cardiology. 122:93–100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vuong L, Brobst DE, Ivanovic I, Sherry DM
and Al-Ubaidi MR: p53 selectively regulates developmental apoptosis
of rod photoreceptors. PLoS One. 8:e673812013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma YX, Guo Z and Sun T: CGRP inhibits
norepinephrine induced apoptosis with restoration of Bcl-2/Bax in
cultured cardiomyocytes of rat. Neurosci Lett. 549:130–134. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu YH, Xiong J, Wang SS, Tang D, Wang RS
and Zhu Q: Calycosin entered HUVECs and ameliorated AGEs-promoted
cell apoptosis via the Bcl-2 pathway. J Nat Med. 68:163–172. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zeng C, Ke Z, Song Y, et al: Annexin A3 is
associated with a poor prognosis in breast cancer and participates
in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax
balance. Exp Mol Pathol. 95:23–31. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takahashi K, Ouyang X, Komatsu K, et al:
Sodium tanshinone IIA sulfonate derived from Danshen (Salvia
miltiorrhiza) attenuates hypertrophy induced by angiotensin II
in cultured neonatal rat cardiac cells. Biochem Pharmacol.
64:745–749. 2002.PubMed/NCBI
|
|
20
|
Ouyang X, Takahashi K, Komatsu K, et al:
Protective effect of Salvia miltiorrhiza on angiotensin
II-induced hypertrophic responses in neonatal rat cardiac cells.
Jpn J Pharmacol. 87:289–296. 2001.
|
|
21
|
Zengyong Q, Jiangwei M and Huajin L:
Effect of Ligusticum wallichii aqueous extract on oxidative
injury and immunity activity in myocardial ischemic reperfusion
rats. Int J Mol Sci. 12:1991–2006. 2011.
|
|
22
|
Yu L, She T, Li M, Shi C, Han L and Cheng
M: Tetramethylpyrazine inhibits angiotensin II-induced
cardiomyocyte hypertrophy and tumor necrosis factor-α secretion
through an NF-κB-dependent mechanism. Int J Mol Med. 32:717–722.
2013.PubMed/NCBI
|
|
23
|
Roe ND and Ren J: Oxidative activation of
Ca(2+)/calmodulin-activated kinase II mediates ER stress-induced
cardiac dysfunction and apoptosis. Am J Physiol Heart Circ Physiol.
304:H828–H839. 2013.
|
